ES2038600T3 - Composiciones para uso terapeutico comprendiendo compuestos organo-siliceos. - Google Patents

Composiciones para uso terapeutico comprendiendo compuestos organo-siliceos.

Info

Publication number
ES2038600T3
ES2038600T3 ES198686450026T ES86450026T ES2038600T3 ES 2038600 T3 ES2038600 T3 ES 2038600T3 ES 198686450026 T ES198686450026 T ES 198686450026T ES 86450026 T ES86450026 T ES 86450026T ES 2038600 T3 ES2038600 T3 ES 2038600T3
Authority
ES
Spain
Prior art keywords
organosilicon compound
litre
hyposulphite
solution
osir3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686450026T
Other languages
English (en)
Inventor
Loic Le Ribault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2038600T3 publication Critical patent/ES2038600T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION CONCIERNE A UNA COMPOSICION PARA USO TERAPEUTICO, PRINCIPALMENTE UTIL PARA EL TRATAMIENTO DEL ASMA Y FENOMENOS ALERGICOS EN GENERAL, SINUSITIS, HERPES Y HEPATITIS VIRAL, DE LA ZONA DE ENFERMEDADES VIRALES EN GENERAL CARACTERIZADO PORQUE COMPRENDE UNA SOLUCION ACUOSA: (1) AL MENOS UN COMPUESTO ORGANO-SILICIO DE CUALQUIERA DE LAS FORMULAS (A) O (B) EN LAS QUE: - N ES UN NUMERO ENTERO COMPRENDIDO ENTRE 1 Y 1000 Y DE PREFERENCIA ENTRE 1 Y 50; - P, Q, R SON NUMEROS ENTEROS COMPRENDIDOS ENTRE 0 Y 1000 Y DE PREFERENCIA ENTRE 0 Y 60; - R Y R''REPRESENTAN INDEPENDIENTEMENTE EL UNO DEL OTRO UN GRUPO ALIFATICO LINEAL, RAMIFICADO O CICLICO, SATURADO O NO, Y COMPRENDIENDO EVENTUALMENTE HETEROATOMOS, O AROMATIZADOS, HETEROAROMATICO, ARILALIFATICO, O HETEROARILALIFATICO, EVENTUALMENTE SUSTITUIDOS POR GRUPOS FUNCIONALES ; R PUEDE TAMBIEN SER OH, OR O OSIR3. - (SIGMA) ES R O H O SIR3; - (SIGMA)'' ES ESCOGIDO ENTRE R Y MAS PARTICULARMENTE CH3 U OR, U OH O OSIR3, O LAS SALES DE METAL ALCALINO ODE ADICION CON UN ACIDO FARMACEUTICAMENTE ACEPTABLE, EN DICHO COMPUESTO, EL/LOS COMPUESTO/S ORGANO - SILICIO/S ESTA/N UTILIZADO/S EN CONCENTRACIONES VARIANDO DE 10 ELEVADO A - 5 A 10 ELEVADO A - 2 ATOMOS - GRAMO/LITRO DE AGUA, Y (2) DE HIPOSULFITO DE SODIO (NA2S2O3.5H2O) O DE MAGNESIO, SIENDO LA RELACION DE (1) A (2) DE 5 A 50G DE HIPOSULFITO POR LITRO DE SOLUCION DE ORGANO - SILICIO. TIENE APLICACION PRINCIPALMENTE EN EL TRATAMIENTO DE FENOMENOS ALERGICOS.
ES198686450026T 1985-12-23 1986-12-22 Composiciones para uso terapeutico comprendiendo compuestos organo-siliceos. Expired - Lifetime ES2038600T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8519204A FR2591890B1 (fr) 1985-12-23 1985-12-23 Composition a usage therapeutique comprenant des composes organo-silicies

Publications (1)

Publication Number Publication Date
ES2038600T3 true ES2038600T3 (es) 1993-08-01

Family

ID=9326177

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686450026T Expired - Lifetime ES2038600T3 (es) 1985-12-23 1986-12-22 Composiciones para uso terapeutico comprendiendo compuestos organo-siliceos.

Country Status (8)

Country Link
US (1) US5391546A (es)
EP (1) EP0228978B1 (es)
AT (1) ATE62596T1 (es)
CA (1) CA1292688C (es)
DE (1) DE3678813D1 (es)
ES (1) ES2038600T3 (es)
FR (1) FR2591890B1 (es)
GR (1) GR3002313T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384312A (en) * 1987-05-08 1995-01-24 Merrell Dow Pharmaceuticals Inc. Substituted silyl alkylene amines
FR2684002A1 (fr) * 1991-11-26 1993-05-28 Duffaut Norbert Traitement du sida au moyen de compositions aqueuses dont la base incontournable a ce jour est constituee, avant potentialisation, de derives organosilicies.
EP2043663B1 (en) * 2006-07-25 2014-03-19 ITH Immune Therapy Holdings AB Topical treatment of warts
DE102015224732A1 (de) 2015-12-09 2017-06-14 Wacker Chemie Ag Verfahren zur Herstellung von Siloxanolen aus Metallsalzen von Silanolen
BE1023898B1 (fr) 2016-08-25 2017-09-07 Sil'innov Scrl Composition comprenant du silicium et son procédé de préparation
EP3613749A4 (en) * 2017-04-20 2020-12-16 National Institute of Advanced Industrial Science and Technology SILANOL COMPOUND AND METHOD FOR PRODUCING A SILANOL COMPOUND
PL239956B1 (pl) 2018-12-10 2022-01-31 Jednostka Innowacyjno Wdrozeniowa Inwex Spolka Z Ograniczona Odpowiedzialnoscia Kompleksowe związki krzemu organicznego, sposób otrzymywania kompleksowych związków krzemu organicznego oraz zastosowanie kompleksowych związków krzemu organicznego

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764673A (en) * 1971-02-19 1973-10-09 Alza Corp Pharmaceutical compositions comprising alkylsilyl ethers of prostaglandins
FR2158068B1 (es) * 1971-10-25 1975-02-07 Gueyne Jean
FR2160293A1 (en) * 1971-11-18 1973-06-29 Gueyne Jean Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity
FR2230376A1 (en) * 1973-05-24 1974-12-20 Gueyne Jean Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity
US4148885A (en) * 1973-09-25 1979-04-10 Institut Merieux Immunostimulant medicine

Also Published As

Publication number Publication date
GR3002313T3 (en) 1992-12-30
DE3678813D1 (de) 1991-05-23
FR2591890B1 (fr) 1988-03-04
FR2591890A1 (fr) 1987-06-26
CA1292688C (fr) 1991-12-03
US5391546A (en) 1995-02-21
ATE62596T1 (de) 1991-05-15
EP0228978B1 (fr) 1991-04-17
EP0228978A1 (fr) 1987-07-15

Similar Documents

Publication Publication Date Title
IL86040A (en) Acid stable purine dideoxynu- cleosides, their preparation and pharmaceutical compositions containing them
ATE115958T1 (de) Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile.
NO306408B1 (no) L-nukleosidforbindelse, anvendelse derav og farmasöytisk sammensetning
IS1262B6 (is) Ný samsetning efnis
DK403187A (da) Praeparat til transdermal indgift
ES2038600T3 (es) Composiciones para uso terapeutico comprendiendo compuestos organo-siliceos.
HK1005739A1 (en) Griseolic acid derivatives their preparation and their use
IL65787A0 (en) Antiviral pharmaceutical compositions containing alpha,alpha-dialkyl-adamantylamines
ES8306378A1 (es) "un procedimiento para la preparacion de derivados de adenosina".
IL81702A (en) 7-(1-pyrrolidinyl)-quinolone-carboxylic acid derivatives,their preparation and pharmaceutical and veterinary compositions containing them
EP0134179A3 (en) Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, their use as medicines and compositions containing them
DE3065428D1 (en) Derivative of creatinol-o-phosphate having therapeutical action, process for the preparation thereof and related pharmaceutical compositions
EP0294069A3 (en) Purine compounds, process for their preparation, intermediates and pharmaceutical compositions
DE69122462T2 (de) 5-Amino-substituierte Adenosinanaloga als Immunsuppressiva
SE8205837D0 (sv) Isopropylamino pyrimidine derivative its preparation and therapeutic compositions containing the same
SE8400451D0 (sv) Bronchodilatory azepino /1,2-a/pyrimidine derivatives and acid addition salts thereof and pharmaceutical compositions containig same
GB8829478D0 (en) Formulations
DK583887D0 (da) 4-hydroxy-4-(substitueret alkenyl)-cyclohexancarboxylsyrer og deres fremstilling
JPS5673022A (en) Antiviral agent

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 228978

Country of ref document: ES